Preventing group B streptococcal infections in newborns

Area of Science:

• Neonatal Health
• Infectious Diseases
• Obstetrics

Background:

• Group B Streptococcus (GBS) remains a primary cause of early-onset neonatal infections despite intrapartum antibiotic prophylaxis (IAP).
• Approximately 2% of neonates exposed to GBS develop severe conditions like sepsis, pneumonia, or meningitis.
• Effective prevention strategies are crucial for reducing neonatal morbidity and mortality.

Purpose of the Study:

• To review the epidemiology and clinical manifestations of GBS infections in neonates.
• To emphasize the impact of screening and prevention guidelines on reducing early-onset GBS disease.
• To provide clinicians with essential knowledge for identifying, managing, and preventing GBS infections.

Main Methods:

• Literature review of studies on GBS screening, prophylaxis, and neonatal outcomes.
• Analysis of data on the incidence and clinical presentation of early-onset GBS disease.
• Synthesis of current clinical guidelines for GBS management.

Main Results:

• Late pregnancy screening for GBS significantly reduces the incidence of early-onset sepsis by over 80%.
• Despite IAP, GBS continues to be a major pathogen in neonatal infections.
• Understanding risk factors and clinical signs is vital for timely diagnosis and treatment.

Conclusions:

• Universal screening in late pregnancy is a highly effective strategy for preventing early-onset GBS disease.
• Clinicians require updated knowledge on GBS risk factors, manifestations, and management protocols.
• Continued vigilance and adherence to prevention guidelines are essential for protecting neonates from GBS infections.